Grow Your Wealth
with Mutual Funds
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 6,293.1 Cr.
NAV as on 24 jul, 2026
₹ 25.03
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw
Inception Date
13 Jul 2018
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
96.05%
Cash
3.95%
Portfolio Updated on: 09 Jul, 2026
Sector Allocations
Equity
Debt
Healthcare
Industrials
Materials
Financial
Portfolio Updated on: 24 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.83% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.05% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.88% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.88% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.21% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.11% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.20% |
Debt & Credit Risk Analysis
| Alpha | 1.19% |
| Beta | 0.95% |
| Sharpe Ratio | 1.10% |
| Standard Deviation | 16.38% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 11.22% | NA | 6.12% |
| 6 Months | 14.67% | NA | 12.92% |
| 9 Months | 6.13% | NA | 4.47% |
| 1 Year | 5.40% | 5.40% | 6.04% |
| 2 Years | 24.81% | 11.72% | 24.93% |
| 3 Years | 88.32% | 23.49% | 25.71% |
| 5 Years | 103.24% | 15.24% | 19.91% |
| 7 Years | 347.97% | 23.89% | NA |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 13 Jul 2018, the fund aims Long term wealth creation. An equity Scheme that predominantly invests in pharma, healthcare, hospitals, diagnostics, wellness and allied companies. It manages assets worth ₹6,293.1 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.87%.
Sharmila D'Silva has experience She joined ICICI Prudential AMC Limited in September 2016.
Dharmesh Kakkad has experience He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| SBI Healthcare Opportunities Fund-idcw | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-idcw | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from ICICI Prudential Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Nifty Healthcare Etf-growth | 157.4 | +1.95% | +11.70% | +16.79% | +10.70% | +21.21% | +13.18% |
| ICICI Prudential Nifty Pharma Index Fund-growth | 104.7 | +2.22% | +13.14% | +17.53% | +12.88% | +20.47% | — |
| ICICI Prudential Nifty Pharma Index Fund Direct-growth | 104.7 | +2.27% | +13.33% | +17.92% | +13.60% | +21.23% | — |
| ICICI Prudential Nifty Pharma Index Fund-idcw | 104.7 | +2.22% | +13.14% | +17.53% | +12.88% | +20.47% | — |
| ICICI Prudential Nifty Pharma Index Fund Direct-idcw | 104.7 | +2.27% | +13.33% | +17.92% | +13.60% | +21.23% | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹574.88 | +23.77% | +17.21% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹399.41 | +23.77% | +17.21% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹46.62 | +24.54% | +16.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.15 | +24.54% | +16.25% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹496.93 | +22.49% | +15.98% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹313.04 | +22.49% | +15.98% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.04 | +21.75% | +15.57% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 24 Jul 2026 | ₹25.03 |
| 23 Jul 2026 | ₹25.07 |
| 22 Jul 2026 | ₹25.23 |
| 21 Jul 2026 | ₹25.61 |
| 20 Jul 2026 | ₹25.58 |
| 17 Jul 2026 | ₹25.27 |
| 16 Jul 2026 | ₹25.56 |
| 15 Jul 2026 | ₹25.57 |
| 14 Jul 2026 | ₹25.50 |
| 13 Jul 2026 | ₹25.32 |
| 10 Jul 2026 | ₹25.42 |
| 09 Jul 2026 | ₹25.21 |
| 08 Jul 2026 | ₹24.99 |
| 07 Jul 2026 | ₹25.28 |
| 06 Jul 2026 | ₹25.43 |
| 03 Jul 2026 | ₹25.42 |
| 02 Jul 2026 | ₹25.14 |
| 01 Jul 2026 | ₹25.03 |
| 30 Jun 2026 | ₹25.12 |
| 29 Jun 2026 | ₹24.92 |
| 25 Jun 2026 | ₹24.87 |
| 24 Jun 2026 | ₹24.95 |
| 23 Jun 2026 | ₹24.85 |
| 22 Jun 2026 | ₹24.65 |
| 19 Jun 2026 | ₹24.36 |
| 18 Jun 2026 | ₹24.28 |
| 17 Jun 2026 | ₹24.13 |
| 15 Jun 2026 | ₹24.21 |
| 12 Jun 2026 | ₹24.24 |
| 11 Jun 2026 | ₹24.03 |
Portfolio Updated on: 25 Jul, 2026
Fund Growth & Size Analysis
+₹6,293.1 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw Returns Comparison
Compare ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
ICICI Prudential Pharm....
No funds found for your search.
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw FAQ'S
- Sharpe Ratio: 1.10%
- Standard Deviation: 16.38%
- Beta: 0.95%
- Alpha: 1.19%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw stand at approximately ₹ 6,293.1 crore.
The ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw has delivered the following short-term performance:
- 3 Months Return: 11.22%
- 6 Months Return: 14.67%
The historical growth of the ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 23.49%
- 5 Year CAGR: 15.24%
- Return Since Launch: 19.87%
The portfolio of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw is distributed across different asset classes as follows:
- Equity: 96.05%
- Other Assets: 3.95%
The ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw is managed by Dharmesh Kakkad, representing ICICI Prudential Mutual Fund.
The ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 12.83% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.05% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.88% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.88% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.21% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.11% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.20% of the portfolio
Major sector exposures in ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw are:
- Healthcare – accounts for 939.01% of the portfolio
- Industrials – accounts for 21.59% of the portfolio
- Materials – accounts for 13.51% of the portfolio
- Financial – accounts for 5.74% of the portfolio
